FOXA1-OE was unable to reverse the tumor growth retardation resulting from the deletion of HNF4G, suggesting that HNF4G is the dominant transcription factor in the primary tumor context, whereas FOXA1 appears to lack any tumor-promoting activity in this context. This evidence concerns the gene FOXA1 and neoplasm.